Shillong, Dec 12: In a boon for the patients of the entire North Eastern Region and Meghalaya in particular, the first Polymerase Chain Reaction (PCR) technology based NAT (Nucleic Acid Testing) machine in Meghalaya was launched into service at NEIGRIHMS on Tuesday.
The machine has been installed in the Department of Transfusion Medicine and Blood Centre, NEIGRIHMS.
Nucleic Acid Testing (NAT) is a molecular technique for screening the blood that has been donated by donors to reduce the risk of transfusion transmitted infections (TTIs) in recipients, thus providing an additional layer of blood safety.
Transfusion of the safest quality of blood is given utmost importance in modern medical care. There are very serious viruses and bacteria that can be transmitted through blood, e.g., HIV 1 and 2, Hepatitis B, Hepatitis C, Syphilis, Malaria, CMV, HTLV etc.
NAT can detect low levels of these viruses in blood and it can also identify occult hepatitis B carrier status, which can be infectious.
In India, as per the Drugs Licensing guidelines, mandatory testing of the above mentioned first five diseases should be performed on all donated units before issue for transfusion.
Technologies such as this PCR/TMA based NAT testing markedly improve the safety of blood by reducing the window period from weeks and months to just a few days.
NEIGRIHMS plans to evolve a mechanism to offer blood testing facility using this state-of-the-art technology to other Blood Centres in the region.
Read:Â Meghalaya remembers Pa Togan Sangma on 152nd death anniversary
WATCH:
Find latest news from every corner of Northeast India at hubnetwork.in, your online source for breaking news, video coverage.
Also, Follow us on-
Twitter-twitter.com/nemediahub
Youtube channel-Â www.youtube.com/@NortheastMediaHub2020
Instagram-Â www.instagram.com/ne_media_hub
Download our app from playstore – Northeast Media Hub
 technology based NAT (Nucleic Acid Testing) machine in Meghalaya was launched into service at NEIGRIHMS on Tuesday.){kind=link}